Why do some COVID-19 patients die? New research reveals shocking cause

  • Context: COVID 
  • Thread starter Thread starter Astronuc
  • Start date Start date
  • Tags Tags
    Covid-19
Click For Summary
SUMMARY

Recent research published in Science reveals that approximately 10% of nearly 1,000 COVID-19 patients who developed life-threatening pneumonia possess autoantibodies that disable key immune proteins known as interferons. This phenomenon, particularly observed in men, indicates that these autoantibodies lead to self-attack by the immune system. Additionally, 3.5% of critically ill patients exhibited mutations in genes regulating interferon responses. This breakthrough finding by the Covid Human Genetic Effort, involving 200 research centers across 40 countries, could pave the way for targeted immunotherapy treatments.

PREREQUISITES
  • Understanding of autoantibodies and their role in autoimmune responses
  • Familiarity with interferon signaling pathways in the immune system
  • Knowledge of genetic mutations affecting immune responses
  • Awareness of COVID-19 pathophysiology and its complications
NEXT STEPS
  • Research targeted immunotherapy approaches for COVID-19 patients
  • Explore the role of interferons in viral infections and immune modulation
  • Investigate genetic testing for autoantibodies in severe COVID-19 cases
  • Study the implications of the Covid Human Genetic Effort's findings on future treatments
USEFUL FOR

Healthcare professionals, immunologists, researchers in virology, and anyone involved in developing therapies for severe COVID-19 cases will benefit from this discussion.

Astronuc
Staff Emeritus
Science Advisor
Gold Member
2025 Award
Messages
22,525
Reaction score
7,502
NBC News - 'Breakthrough finding' reveals why certain Covid-19 patients die
https://www.nbcnews.com/health/heal...ls-why-certain-covid-19-patients-die-n1247576
In some cases, provocative new research shows, some people — men in particular — succumb because their immune systems are hit by friendly fire. Researchers hope the finding will help them develop targeted therapies for those patients.

In an international study in Science, 10 percent of nearly 1,000 Covid-19 patients who developed life-threatening pneumonia had antibodies that disable key immune system proteins called interferons. These antibodies — known as autoantibodies, because they attack the body itself — weren't found at all in 663 people with mild or asymptomatic Covid-19 infections. Only four of 1,227 healthy patients had the autoantibodies. The study was led by the Covid Human Genetic Effort, which includes 200 research centers in 40 countries.

In a second Science study by the same team, the authors found that an additional 3.5 percent of critically ill patients had mutations in genes that control the interferons involved in fighting viruses.

Is this a major step in understanding how the virus works and eventually finding an improved treatment? Target immunotherapy?
 
  • Informative
  • Like
Likes   Reactions: atyy, FactChecker and Charles Link
Biology news on Phys.org

Similar threads

  • · Replies 12 ·
Replies
12
Views
3K
  • · Replies 12 ·
Replies
12
Views
2K
  • · Replies 8 ·
Replies
8
Views
2K
  • · Replies 1 ·
Replies
1
Views
1K
  • · Replies 2 ·
Replies
2
Views
2K
  • · Replies 2 ·
Replies
2
Views
2K
  • · Replies 1 ·
Replies
1
Views
4K
  • · Replies 6 ·
Replies
6
Views
3K
  • · Replies 26 ·
Replies
26
Views
5K
  • · Replies 1 ·
Replies
1
Views
2K